In This Section:
Transradial Intervention
Transradial artery access (TRA) for diagnostic CA or percutaneous coronary intervention (PCI) is associated with lower bleeding and vascular complications than transfemoral artery access (TFA). The European Society of Cardiology guidelines and American Heart Association support a TRA first strategy and evidence also supports an improvement in healthcare quality, and reduced cost. While TFA predominates peripheral interventions, increases in dedicated equipment and the technical expertise may result in TRA as a preferred access in this patient group as well.
Section Advisor
Professor James Nolan
University Hospital North Staffordshire, Stoke-on-Trent, UK
The Radcliffe Transradial Intervention educational programme is supported by:
Media
Recent Videos
Clinical trials
Alehaideb A, Ha W, Bickford S, et al. Circ Cardiovasc Interv 2020;13.
Jiménez Díaz VA, Hovasse T, Íñiguez A, et al. Rev Esp Cardiol (Engl Ed) 2020;73:536–45.
Weinberg JH, Sweid A, Sajja K, et al. J Neurosurg 2020; epub ahead of press.
Guedeney P, Thiele H, Kerneis M, et al. Am Heart J 2020;225:60-68.
Adnan SM, Romagnonli AN, Elansary NN, et al. J Trauma Acute Care Surg 2020;Online ahead of print.
Zhang Z, Bai J, Huang Y, Wang L. Medicine (Baltimore) 2020;99:e22866.
Review
Davies RE, Gilchrist IC. Interv Cardiol Clin 2019;8:111–9.
Risks
Lee YK, Lee SH, Kwon TY. J Hand Surg Eur Vol 2020;45:852–6.
Swersky A, Mohan P. J Card Surg 2020;35:2375–78.
Tehrani BN, Damluji AA, Sherwood MW, et al. Catheter Cardiovasc Interv 2020; epub ahead of press.